Back to results
US 9,518,080 B2Granted
Androstane and pregnane steroids with potent allosteric GABA receptor chloride ionophore modulating properties
AssigneesResearch Triangle Institute, The United States of America, as represented by the Secretary, Department of Health and Human Services
InventorsScott P Runyon, Michael Rogawski, Edgar Cook, John Kepler, Hernan Navarro, Rafal Kaminski, Matthew Orr
Life of this patent
Estimating the term…
Abstract
This invention describes compounds of Structures 1, 2, and 3 and their use as allosteric modulators of the GABA receptor chloride ionophore complex to alleviate stress, anxiety, mood disorders, seizures, depression, treatment of drug and alcohol abuse, memory, premenstrual disorders, and neural system damage.
Claims4
A compound of structure 3′, wherein:
- R1is H or (optionally substituted) C1-4 alkyl, C3-6 cycloalkyl, C2-4 alkynyl, C2-4 alkenyl, C6-10 aryl, 2-arylsubstituted ethynyl, arylsubstituted C1-4 alkyl, arylsubstituted C2-4-alkenyl, arylsubstituted C3-6 cycloalkyl, heterocycle, 2-heterocycle-substituted ethynyl, heterocycle-substituted C1-4 alkyl, heterocycle-substituted C2-4-alkenyl, or heterocycle-substituted C3-6 cycloalkyl;
- R2 group is OH or OR14, where R14 is HCO— or (optionally substituted) C2-18 alkyl-CO—, C2-18 alkenyl-CO—, C2-18 alkynyl-CO—, C6-10 aryl-CO— or heterocycle-CO—;
- or R14 is (optionally substituted) C1-18 alkyl-X—CO—, C2-18 alkenyl-X—CO—, C2-18 alkynyl-X—CO—, C6-10 aryl-X—CO— or heterocycle-X—CO—;
- or R14 is trimethylsilyl or triethylsilyl;
- or R14 is (optionally substituted) C1-4 alkyl, C3-6 cycloalkyl, C2-4 alkenyl, or C2-4 alkynyl, or;
- or R14 is HO—SO2— or a salt thereof or R2 is NR15R16, where R15 is H, OH or (optionally substituted) C1-4 alkyl, C3-6 cycloalkyl, C2-4 alkynyl, C2-4 alkenyl, C6-10 aryl, heterocycle or R15 is OR17, where R17 is (optionally substituted) C1-4 alkyl, C3-6 cycloalkyl, C2-4 alkynyl, C2-4 alkenyl, C6-10 aryl, or heterocycle, C1-18 alkyl-CO—, C2-18 alkenyl-CO—, C2-18 alkynyl-CO—, C6-10 aryl-CO— or heterocycle-CO—;
- and where R16 is H or (optionally substituted) C1-4 alkyl, C3-6 cycloalkyl, C2-4 alkynyl, C2-4 alkenyl, C6-10 aryl, or heterocycle, or R16 is H-CO— or (optionally substituted) C1-18 alkyl-CO—, C2-18 alkenyl-CO—, C2-18 alkynyl-CO—, C3-6 cycloalkyl-CO—, C6-10 aryl-CO— or heterocycle-CO—;
- where X is O or NR100, where R100 is (optionally substituted) C1-4 alkyl, C3-6 cycloalkyl, C2-4 alkenyl, C2-4 alkynyl C6-10 aryl or heterocycle;
- or
- X is NOR110, where R110 is H or C1-6 alkyl, C3-8 cycloalkyl, C2-6 alkenyl, C2-6 alkynyl, C6-12 aryl, or heteroaryl, any of which is optionally substituted;
- or
- X is
- where Y is —(CH2)m— where m is an integer of 0 to 3, or Y is —(CH2)n—Z—(CH2)p— where n is an integer of 0 to 2, p is an integer of 0 to 2 and Z is a heteroatom (optionally substituted) or Z is a carbon atom substituted with one or two C1-6 alkyl groups;
- R3 is H, halogen, cyano, azido or (optionally substituted) C1-4 alkyl, C3-6 cycloalkyl, C2-4 alkynyl, C2-4 alkenyl, C6-10 aryl, or heterocycle;
- R4 is H or (optionally substituted) Me;
- R6 is H, or (optionally substituted) C1-8 alkyl, C3-6 cycloalkyl, C2-8 alkenyl, C2-8 alkynyl, C6-10 aryl or heterocycle;
- R8 is H, halogen, azido, cyano, thiocyano, ═O, OH, OR16 (where R16 is as defined above);
- or R8 is NH2 or NR15R16 (where R15 and R16 are as defined above);
- or R8 is (optionally substituted) C1-18 alkyl, C3-6 cycloalkyl, C2-18 alkynyl, C2-18 alkenyl, C6-10 aryl or heterocycle;
- or R8 is COOR18 where R18 is (optionally substituted) C1-4 alkyl, C3-6 cycloalkyl, C2-4 alkenyl, C2-4 alkynyl, C6-10 aryl, or heterocycle;
- or R8 is S(O)nR16, where R16 is as defined above and n=0, 1, or 2;
- R9 is H, cyano, azido, halogen, thiocyano, OH, OR16, where R16 is as defined above, or R9 is (optionally substituted) C1-4 alkyl, C3-6 cycloalkyl, C2-4 alkynyl, C2-4 alkenyl, C6-10 aryl, 2-arylsubstituted ethynyl, arylsubstituted C1-4 alkyl, arylsubstituted C2-4-alkenyl, arylsubstituted C3-6 cycloalkyl, heterocycle;
- 2-heterocycle-substituted ethynyl, heterocycle-substituted C1-4 alkyl, heterocycle-substituted C2-4-alkenyl, heterocycle-substituted C3-6 cycloalkyl;
- R10 is H, keto, halogen, cyano, thiocyano, azido or NR15R16, where R15 and R16 are as defined above;
- or R10 is (optionally substituted) C1-4 alkyl, C3-6 cycloalkyl, C2-4 alkynyl, C2-4 alkenyl, C6-10 aryl or heterocycle;
- or R10 is S(O)nR16, where R16 is as defined above and n=0, 1, or 2;
- or R10 is OR16 where R16 as defined above or R16 is trimethylsilyl or triethylsilyl;
- R11 is C1-18 alkyl, C2-18 alkenyl, C2-18 alkynyl, C3-8 cycloalkyl, C6-12 aryl, aralkyl, aralkenyl, aralkynyl, heteroaryl, heteroaralkyl, heteroaralkenyl or heteroaralkynyl any of which is optionally substituted;
- or
- R11 is
- where R50 and R60 are each independently H;
- halogen;
- (R70R80N(O)r)—, where r is 0 or 1 and R70 and R80 are each independently H, C1-6 alkyl, C3-8 cycloalkyl, C2-6 alkenyl or C2-6 alkynyl, any of which is optionally substituted;
- substructure II,
- where q is 0 or 1, Y is —(CH2)m— where m is an integer of 0 to 5, or Y is —(CH2)n—Z—(CH2)p— where n is an integer of 0 to 2, p is an integer of 0 to 2, and Z is a heteratom (optionally substituted) and where the CH2 groups are optionally substituted;
- N-imidazolyl;
- —N-pyrrolyl-;
- HO—;
- CF3SO2O—;
- C1-6 alkyl-O—;
- C1-6 perfluoroalkyl-O—;
- C1-6 alkyl-S—;
- C1-6 alkyl-CH(OH)—;
- NC—;
- HCC—;
- C6H5CC—;
- 2′-furyl;
- 3′-furyl;
- 2′-thiophenyl;
- 3′-thiophenyl;
- 2′-pyridyl;
- 3′-pyridyl;
- 4′-pyridyl;
- 2′-thiazolyl;
- 2′-N-methylimidazolyl;
- 5′-pyrimidinyl;
- C6H5—;
- H2C═CH—;
- C1-6 alkyl;
- MeC(═CH2)—;
- C1-6 alkyl-CO;
- HCO;
- C1-6 alkyl;
- C═NOR120, or HC═NOR120, where R120 is H or C1-6 alkyl, C3-8 cycloalkyl, C2-6 alkenyl, C2-6 alkynyl, C6-12 aryl, or heteroaryl, any of which is optionally substituted;
- or R50 and R60 combine to form a ring
- where W is CH2, CH, NH, N, O, or S, and R90 is H or C1-6 alkyl;
- or R50 and R60 combine to form a ring
- where A and B are each independently H, F or C1-6 alkyl or A and B combine to form ═O;
- or R50 and R60 combine to form a ring
- where the CH2 groups are independently and optionally substituted;
- and
- R13 is nitro;
- J is one of S, SO or SO2;
- J′ is one of O, S, SO or SO2;
- Q is one of C1-4 alkyl, C2-4 alkenyl or C2-4 alkynyl;
- G is one of C-attached hetero-C5-10-aryl, optionally substituted C6-10 aryl, a quaternary ammonium salt of a nitrogen containing hetero-C5-10-aryl group or a quarternary salt of an amino substituted C6-10 aryl group;
- T is C-attached hetero-C5-10-aryl or a quaternary ammonium salt of a nitrogen containing hetero-C5-10-aryl group;
- E is optionally substituted C6-10 aryl or a quaternary ammonium salt of an amino substituted C6-10 aryl group;
- L is one of amino, amido, cyano, thiocyano, azido, nitro, hydroxy, halo, carboxyl, C1-4 alkoxy, C1-4 alkoxycarbonyl, C1-4 alkanoyloxy, hydrogen, sulfate, thiosulfate, sulfonate, C1-4 alkylthio, C1-4 alkylsulfinyl, C1-4 alkylsulfonyl or mercapto. and stereoisomers thereof.
76 more elements
A compound of structure 6, wherein
- R1 is H or (optionally substituted) C1-4 alkyl, C3-6 cycloalkyl, C2-4 alkynyl, C2-4 alkenyl, C6-10 aryl, 2-arylsubstituted ethynyl, arylsubstituted C1-4 alkyl, arylsubstituted C2-4-alkenyl, arylsubstituted C3-6 cycloalkyl, heterocycle;
- 2-heterocycle-substituted ethynyl, heterocycle-substituted C1-4 alkyl, heterocycle-substituted C2-4-alkenyl, or heterocycle-substituted C3-6 cycloalkyl;
- and
- R4 is H or (optionally substituted) Me;
- and stereoisomers thereof.
2 more elements
Dependencies are inferred from the claim text.